pilipiliÂþ»­

 

Funding, News and Announcements

» Go to news main

Canadian Institute for Military and Veteran Health Research

Posted by Jaq-Lin Larder on March 4, 2024 in Research Funding

Two new opportunities are available through the Joint Federal Research Funding Program for Military Personnel and Veterans.

This research funding program aims to enhance the well-being of Canadian Armed Forces members, Veterans, and their families by supporting Canadian research focused on supporting these populations. This joint initiative is the result of a partnership between Veterans Affairs Canada (VAC), Defence Research and Development Canada (DRDC), the Canadian Forces Health Services (CFHS) and the Canadian Institute for Military and Veteran Health Research (CIMVHR).

1. Development of a functional test battery for concussion/brain injury to promote recovery and reduce future risk of potential brain and musculoskeletal injuries.

This funding opportunity is seeking submissions to develop a resource-lean test battery for mild brain injuries that encompasses all the essential elements of an active military population, including heart-rate elevation, multi-planar movement, and multi-tasking, that can be administered in non-clinical environments, to assess deficits in the coordination of cognition and movement, and can be used to predict future brain and MSK injuries and to help inform the management and recovery of individuals following an acute concussion or mild traumatic brain injury (mTBI) and reduce the risk of future brain and/or MSK injury. The due date for applications isÌýMarch 8, 2024 at 11:59 PM (PST).

2. Feasibility of IV ketamine for the treatment of traumatic brain injury and depression.

DRDC is conducting biomedical and translational research in support of CFHS to evaluate the use of ketamine assisted therapy (KAT) for the treatment of mild traumatic brain injury (mTBI) and related mental health concerns. The purpose of the interventional study is to perform a pragmatic clinical trial to assess the effectiveness of IV KAT in a cohort of female and male CAF members/Veterans and civilian patients suffering from mild TBI with post-concussive symptoms and/or comorbid depression. The due date for applications is March 11, 2024 at 11:59 PM (PST).

Ìý

.

For questions regarding internal procedure, contact theÌýgrants facilitatorÌýfor your faculty. For additional resources,Ìýclick here for guidanceÌýon internal deadlines and submission processes.Ìý